Skip to main content

Animations

MJFF Publications

4291 - 4300 of 8761 Results
Title
Year
  • Year
  • 2021
  • 2024
  • 2024
  • 2020
  • 2018
  • 2023
  • 2015
  • 2024
  • 2013
  • 2023
  • Summary Details
    OPEN
    Title: α‐Synuclein in Plasma‐Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28639
    Citation Count: 83
  • Summary Details
    OPEN
    Title: Targeting short-chain fatty acids receptors signalling for neurological disorders treatment
    Journal Name: Exploration of Neuroprotective Therapy
    Publisher: Open Exploration Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.37349/ent.2024.00073
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Oral Transport, Penetration, and Aspiration in PD: Insights from a RCT on STN + SNr Stimulation
    Journal Name: Dysphagia
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00455-024-10779-y
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Identification and in vitro characterization of C05-01, a PBB3 derivative with improved affinity for alpha-synuclein
    Journal Name: Brain Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.brainres.2020.147131
    Citation Count: 29
  • Summary Details
    OPEN
    Title: The transition between turning and sitting in patients with Parkinson's disease: A wearable device detects an unexpected sequence of events
    Journal Name: Gait & Posture
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.gaitpost.2018.10.018
    Citation Count: 32
  • Summary Details
    RESTRICTED
    Title: Challenges of Parkinson's disease GWASs in African people
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00361-7
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Synthesis of Multiring Fused 2-Pyridones via a Nitrene Insertion Reaction: Fluorescent Modulators of α-Synuclein Amyloid Formation
    Journal Name: Organic Letters
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acs.orglett.5b03190
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Toward the quantification of α-synuclein aggregates with digital seed amplification assays
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2312031121
    Citation Count: 14
  • Summary Details
    RESTRICTED
    Title: The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p06.049
    Citation Count: 2
  • Summary Details
    OPEN
    Title: ATP and NAD+ Deficiency in Parkinson’s Disease
    Journal Name: Nutrients
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/nu15040943
    Citation Count: 26
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.